Market Cap 148.00B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.03
Forward PE 8.09
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 43,435,481
Avg Vol 73,117,133
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 63%
Beta 0.46
Analysts Sell
Price Target $28.32

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 9 at 11:04 PM
0 · Reply
hegdaom
hegdaom Dec. 9 at 9:47 PM
0 · Reply
scor0328
scor0328 Dec. 9 at 9:34 PM
$CAPR $PFE seems so desperate to buy growth, paying up and throwing darts at GLP 1 market. Buy the time they enter, the GLPs will be a commodity. Meanwhile you would think Bourla would be knocking on the door in San Diego for a P3 proven dmd treatment, esp after their failures.
3 · Reply
LeftyT
LeftyT Dec. 9 at 9:19 PM
$ALT Competition update: Pfizer $PFE is being penny wise and pound foolish w/ their Yao Pharma licensing deal. It's a $1.9 B biobucks deal w/ $150 M cash up front, which was critical as Yao didn't have enough cash to finish their ongoing P1 trial. All that for another GLP-1 agonist, all that because they're too cheap to buy out ALT for $4 b and get a P3 ready product. This is on top of their recent purchase of Metsera, after a bidding war w/ Novo Nordisk $NVO , to get yet another GLP-1 drug still in P2b testing. Not sure who's calling the shots on this at Pfizer, but the shotgun accuracy is costing them more than it should. https://www.fiercebiotech.com/biotech/pfizer-continues-renewed-obesity-push-2b-pact-fosun-units-glp-1-drug
2 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 9:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.50 Put · DEC 19, 2025 Exp Entry Price: $0.46 - $0.47 Exit Price Target: $0.64 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Willieberich
Willieberich Dec. 9 at 9:12 PM
$PFE I'm being forced to buy here again..10,000 is coming quickly..
0 · Reply
SeriouslyWhy
SeriouslyWhy Dec. 9 at 9:11 PM
$PFE wow what a pos
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Dec. 9 at 9:06 PM
$PFE Well the good news is the market closed on time
1 · Reply
10dollarput
10dollarput Dec. 9 at 9:05 PM
$PFE This guy fucked us by selling today.
0 · Reply
Latest News on PFE
Down 50%, Should You Buy the Dip on Pfizer?

Dec 9, 2025, 4:15 PM EST - 2 hours ago

Down 50%, Should You Buy the Dip on Pfizer?


Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 12 hours ago

Pfizer partners with YaoPharma for weight management treatment


Do These 3 Healthcare Stocks Need a Checkup?

Dec 5, 2025, 4:05 PM EST - 4 days ago

Do These 3 Healthcare Stocks Need a Checkup?

BMY MRK


2 Headwinds Facing Pfizer Stock Going Into 2026

Dec 5, 2025, 10:05 AM EST - 4 days ago

2 Headwinds Facing Pfizer Stock Going Into 2026


Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 4 days ago

Pfizer: The Market Is Still Wrong About It


2 Top Dividend Stocks to Buy Now and Hold For a Decade

Dec 2, 2025, 7:44 AM EST - 7 days ago

2 Top Dividend Stocks to Buy Now and Hold For a Decade

ABBV


This 7% Yielder Could Be a Top AI Play

Nov 30, 2025, 4:04 PM EST - 9 days ago

This 7% Yielder Could Be a Top AI Play


8 Dividend Stocks Every Investor Should Consider

Nov 28, 2025, 5:30 AM EST - 11 days ago

8 Dividend Stocks Every Investor Should Consider

ABBV AXP COST JPM NVDA PM SPGI


Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 13 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY


Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Nov 26, 2025, 4:15 AM EST - 13 days ago

Did Pfizer Just Say "Checkmate" to Novo Nordisk?


Is This the Best Value Stock to Buy While Markets Are Volatile?

Nov 25, 2025, 6:24 AM EST - 14 days ago

Is This the Best Value Stock to Buy While Markets Are Volatile?


Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 19 days ago

Pfizer Crosses Below Key Moving Average Level


Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Nov 20, 2025, 9:30 AM EST - 19 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?


Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 20 days ago

Pfizer: Is This Pharma Giant Finally A Bargain


Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 20 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug


2 No-Brainer Healthcare Stocks to Buy Now

Nov 18, 2025, 6:45 AM EST - 21 days ago

2 No-Brainer Healthcare Stocks to Buy Now

VKTX


Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

Nov 17, 2025, 9:10 PM EST - 21 days ago

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?


2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Nov 17, 2025, 10:00 AM EST - 22 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

MDT


Down 55%, Should You Buy the Dip on Pfizer?

Nov 17, 2025, 4:35 AM EST - 22 days ago

Down 55%, Should You Buy the Dip on Pfizer?


Turbofueled
Turbofueled Dec. 9 at 11:38 PM
$LEXX $LEXX is going to be the make it or break it for these Big Pharmas pill form…… Better come to the table things are gonna explode at $LEXX 🌋🌋 “As is typical for the GLP-1 drug class, the most frequent adverse events were gastrointestinal -- nausea and vomiting being the two most common side effects during the titration phase.” $GPCR $NVO $LLY $PFE https://www.techtarget.com/pharmalifesciences/news/366636177/Structure-announces-mid-phase-data-for-its-oral-GLP-1-candidate
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 9 at 11:04 PM
0 · Reply
hegdaom
hegdaom Dec. 9 at 9:47 PM
0 · Reply
scor0328
scor0328 Dec. 9 at 9:34 PM
$CAPR $PFE seems so desperate to buy growth, paying up and throwing darts at GLP 1 market. Buy the time they enter, the GLPs will be a commodity. Meanwhile you would think Bourla would be knocking on the door in San Diego for a P3 proven dmd treatment, esp after their failures.
3 · Reply
LeftyT
LeftyT Dec. 9 at 9:19 PM
$ALT Competition update: Pfizer $PFE is being penny wise and pound foolish w/ their Yao Pharma licensing deal. It's a $1.9 B biobucks deal w/ $150 M cash up front, which was critical as Yao didn't have enough cash to finish their ongoing P1 trial. All that for another GLP-1 agonist, all that because they're too cheap to buy out ALT for $4 b and get a P3 ready product. This is on top of their recent purchase of Metsera, after a bidding war w/ Novo Nordisk $NVO , to get yet another GLP-1 drug still in P2b testing. Not sure who's calling the shots on this at Pfizer, but the shotgun accuracy is costing them more than it should. https://www.fiercebiotech.com/biotech/pfizer-continues-renewed-obesity-push-2b-pact-fosun-units-glp-1-drug
2 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 9:14 PM
Hedge Alert Live - Protect Your Portfolio Contract: $PFE $25.50 Put · DEC 19, 2025 Exp Entry Price: $0.46 - $0.47 Exit Price Target: $0.64 Profit Margin: +40% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Willieberich
Willieberich Dec. 9 at 9:12 PM
$PFE I'm being forced to buy here again..10,000 is coming quickly..
0 · Reply
SeriouslyWhy
SeriouslyWhy Dec. 9 at 9:11 PM
$PFE wow what a pos
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Dec. 9 at 9:06 PM
$PFE Well the good news is the market closed on time
1 · Reply
10dollarput
10dollarput Dec. 9 at 9:05 PM
$PFE This guy fucked us by selling today.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Dec. 9 at 9:03 PM
$PFE - Well, it was a shitty day for pharma in general, so…
0 · Reply
MHM7700
MHM7700 Dec. 9 at 9:00 PM
70% gains locked in on the $PFE puts. https://stocktwits.com/MHM7700/message/638534782
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 9 at 9:00 PM
$PFE -3% from pre market high, genuinely fuck this stock
0 · Reply
Youcalledthewolf
Youcalledthewolf Dec. 9 at 8:56 PM
$PFE crazy volume at 2:05 with 250k shares. Large scale institutional trade near the bottom today.
0 · Reply
up2moon
up2moon Dec. 9 at 8:55 PM
$PFE when next pandemic strikes, Bourla will be like
0 · Reply
Ed_Ng
Ed_Ng Dec. 9 at 8:54 PM
$PFE lol this...
0 · Reply
superpiterpan
superpiterpan Dec. 9 at 8:53 PM
$PFE started a new position.
0 · Reply
BuddyBoy6975
BuddyBoy6975 Dec. 9 at 8:51 PM
$ALT $GILD $NVO $PFE $SNY Couple of stars SLOWLY aligning, with a handful still out there. Just give us the dam 48w data Jerry 🙏🙏🙏
0 · Reply
MarcoFla99
MarcoFla99 Dec. 9 at 8:51 PM
$PFE When is the BOD going to force Bourla out?
0 · Reply
BuddyBoy6975
BuddyBoy6975 Dec. 9 at 8:48 PM
$ALT $SNY $NVO $GILD $PFE Markets pricing in a Fed cut tomorrow due to sliding Economic data… Can you say Pharma launching pad….? (Yes)
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 9 at 8:47 PM
$PFE every time my account passes 100k it shits its pants… Have literally passed 100k and lost it almost 20 times in the last year
2 · Reply
LLMAgent
LLMAgent Dec. 9 at 8:43 PM
$PFE - the company locked in eternal zugzwang 😂 Any move they make just makes their position worse and stock drop
0 · Reply